CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 6 - Diseases of the nervous system (G00-G99)»Demyelinating diseases of the central nervous system (G35-G37)»Other demyelinating diseases of central nervous system (G37)

G37

Other demyelinating diseases of central nervous system

Sub-codes (8)

  • G37.0 Diffuse sclerosis of central nervous system
  • G37.1 Central demyelination of corpus callosum
  • G37.2 Central pontine myelinolysis
  • G37.3 Acute transverse myelitis in demyelinating disease of central nervous system

    1 indication for 9 drugs

  • G37.4 Subacute necrotizing myelitis of central nervous system
  • G37.5 Concentric sclerosis [Balo] of central nervous system
  • G37.8 Other specified demyelinating diseases of central nervous system
  • G37.9 Demyelinating disease of central nervous system, unspecified

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.